Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Hepatology (Baltimore, Md.)
|
April 27, 2016
Aquaporin gene therapy for disorders of cholestasis?
Lukmanee Tradtrantip, Alan S Verkman
Expert Opinion on Therapeutic Targets
|
February 20, 2020
Emerging therapeutic targets for neuromyelitis optica spectrum disorder
Lukmanee Tradtrantip, Nithi Asavapanumas, Alan S Verkman
Annals of Neurology
|
October 12, 2012
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody
Lukmanee Tradtrantip, Julien Ratelade, Hua Zhang, et al.
Expert Opinion on Biological Therapy
|
January 29, 2021
Targeting the complement system in neuromyelitis optica spectrum disorder
Nithi Asavapanumas, Lukmanee Tradtrantip, Alan S Verkman
Molecular Pharmacology
|
October 8, 2009
Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels
Lukmanee Tradtrantip, Wan Namkung, A S Verkman
Molecular Pharmacology
|
April 11, 2013
Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase
Lukmanee Tradtrantip, Nithi Asavapanumas, A S Verkman
European Journal of Pharmacology
|
September 2, 2006
Differential effects of hydroxyacetophenone analogues on the transcytotic vesicular pathway in rat liver
Lukmanee Tradtrantip, James L Boyer, Apichart Suksamrarn, et al.
Plos Neglected Tropical Diseases
|
February 20, 2014
Antidiarrheal efficacy and cellular mechanisms of a Thai herbal remedy
Lukmanee Tradtrantip, Eun-A Ko, Alan S Verkman
Scientific Reports
|
November 10, 2021
Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
Lukmanee Tradtrantip, Michael R Yeaman, A S Verkman
Journal of Medicinal Chemistry
|
September 30, 2009
Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model
Lukmanee Tradtrantip, N D Sonawane, Wan Namkung, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Hepatology (Baltimore, Md.)
|
April 27, 2016
Aquaporin gene therapy for disorders of cholestasis?
Lukmanee Tradtrantip, Alan S Verkman
Expert Opinion on Therapeutic Targets
|
February 20, 2020
Emerging therapeutic targets for neuromyelitis optica spectrum disorder
Lukmanee Tradtrantip, Nithi Asavapanumas, Alan S Verkman
Annals of Neurology
|
October 12, 2012
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody
Lukmanee Tradtrantip, Julien Ratelade, Hua Zhang, et al.
Expert Opinion on Biological Therapy
|
January 29, 2021
Targeting the complement system in neuromyelitis optica spectrum disorder
Nithi Asavapanumas, Lukmanee Tradtrantip, Alan S Verkman
Molecular Pharmacology
|
October 8, 2009
Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels
Lukmanee Tradtrantip, Wan Namkung, A S Verkman
Molecular Pharmacology
|
April 11, 2013
Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase
Lukmanee Tradtrantip, Nithi Asavapanumas, A S Verkman
European Journal of Pharmacology
|
September 2, 2006
Differential effects of hydroxyacetophenone analogues on the transcytotic vesicular pathway in rat liver
Lukmanee Tradtrantip, James L Boyer, Apichart Suksamrarn, et al.
Plos Neglected Tropical Diseases
|
February 20, 2014
Antidiarrheal efficacy and cellular mechanisms of a Thai herbal remedy
Lukmanee Tradtrantip, Eun-A Ko, Alan S Verkman
Scientific Reports
|
November 10, 2021
Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
Lukmanee Tradtrantip, Michael R Yeaman, A S Verkman
Journal of Medicinal Chemistry
|
September 30, 2009
Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model
Lukmanee Tradtrantip, N D Sonawane, Wan Namkung, et al.
Page
of 4